Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
This study is currently recruiting participants.
Verified March 2013 by Northwestern University
Sponsor:
Northwestern University
Information provided by (Responsible Party):
Northwestern University
ClinicalTrials.gov Identifier:
NCT01478321
First received: November 17, 2011
Last updated: March 4, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2014 |
| Estimated Primary Completion Date: | November 2014 (Final data collection date for primary outcome measure) |